PT Kalbe Farma Tbk (PTKFF)
0.0714
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
PT Kalbe Farma EPS Diluted (Quarterly) : 0.0009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 40.75M |
| Revenue (Quarterly) | 544.54M |
| Total Expenses (Quarterly) | 504.42M |
| Enterprise Value | 3.124B |
| Gross Profit Margin (Quarterly) | 38.10% |
| Profit Margin (Quarterly) | 7.48% |
| Earnings Yield | 6.58% |
| Operating Earnings Yield | 8.20% |
| Normalized Earnings Yield | 6.583 |